Cited by 136Cancer Cells and MetastasisMechanisms of cancer metastasisCancer, Stress, Anesthesia, and Immune Response

Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency

Open access
Suzuki, Mika, Mose, Evangeline Sari, Montel, Valerie, Tarin, David·2006·The American Journal of Pathology

Abstract

This study shows that solitary, dormant human cancer cells, retrieved from metastasis-free organs of animals carrying spontaneously metastatic primary tumors, can reactivate their tumorigenic and metastatic potency. The tumors were produced by MDA-MB-435 CL16 breast cancer cells permanently labeled with green fluorescent protein and the neomycin resistance gene. This enabled unequivocal identification of tumor cells emerging from organ explants cultured in neomycin to eliminate nonneoplastic host cells. Rescued cells resumed proliferation and generated lines that were tumorigenic and metastatic in fresh animals. All resulting primary and secondary tumors were uniformly labeled. Cells recovered from bone marrows and spleens, where there were no metastases, were as tumorigenic and metastatic as cells recovered from lungs and lymph nodes, which are the preferred sites of colonization for this tumor line. This evidence that malignant growth of disseminated cancer cells is suspended indefinitely by microenvironmental conditions in metastasis-free organs, although it is still active in others of the same host, shows that neoplastic progression can be arrested and has far-reaching biological and clinical implications. Specifically, it predicts the existence of natural, nonimmune host mechanisms that stimulate or inactivate tumor growth in different anatomical sites, which may be exploitable for therapeutic benefit.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2353/ajpath.2006.060053

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The authors' in vivo mouse model showed tumor growth kinetics and incidence similar to dormant cancer cell line models, unlike studies using aggressive cancer cell lines that often produce tumors larger than 100 mm3 within a month after implantation.

    “Importantly, our in vivo mouse model displayed tumor growth kinetics and incidence similar to dormant cancer cell line models [93–96], in contrast to studies relying on aggressive cancer cell lines and resulting often into >100mm3 tumors less than a month after implantation [7].”

    From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [95]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 36 · Cited by 136

Authors
Suzuki, M., Mose, E. S., Montel, V., & Tarin, D.
Affiliations
University of California San Diego (US)
Corresponding author
Tarin, David
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2006-08
Volume
169
Issue
2
Pages
673-681
ISSN
0002-9440 (ISSN-L)
OpenAlex
W2090399120
Cited by
136
References
36
Citations by year
2025: 3 · 2024: 7 · 2023: 9 · 2022: 2 · 2021: 7 · 2020: 11 · 2019: 5 · 2018: 5 · 2017: 6 · 2016: 6 · 2015: 9 · 2014: 3 · 2013: 11 · 2012: 7
FWCI
3.81
Type
journal article
Language
en
Open access
Locations
  • American Journal Of Pathology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
  • Health Sciences › Medicine › Psychiatry and Mental health › Cancer, Stress, Anesthesia, and Immune Response
Keywords
dormant cancer cells, breast cancer, MDA-MB-435 cells, green fluorescent protein tagging, neomycin resistance, bone marrow, spleen, tumor microenvironment, tumor dormancy, metastasis
MeSH terms
Animals, Humans, Neoplasm Metastasis, Neoplasms, Tumor Cells, Cultured, Culture Media, Conditioned, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review